U.S. Tariffs Are Not What Is Holding Back Indian Research

UPSC Syllabus: Gs Paper 3-Industries

Introduction

Recent U.S. tariff tensions have revived concerns that higher duties could weaken Indian research and slow the transition towards higher-value manufacturing. This concern assumes that sectors exposed to tariffs are also the sectors driving India’s innovation. However, an examination of sectoral R&D patterns, private-sector research spending and industrial behaviour suggests that the challenge lies deeper than trade barriers and reflects longstanding structural weaknesses in India’s research ecosystem.

Why Tariffs Raised Concerns About India’s Research Capacity

1. Tariffs can weaken research incentives: Higher duties can reduce export opportunities, raising concerns that firms may cut risky R&D investment and remain in lower-value production.
2. R&D needs market scale: Research is a fixed and risky investment whose returns depend on successfully selling new products at sufficient scale.
3. Smaller markets can change business choices: When exports decline, firms may prefer cheaper, undifferentiated goods instead of investing in products that tariffs cannot easily replace.
4. Past protection shaped industrial behaviour: Before the 1991 economic opening, high tariff barriers protected Indian firms from competition and reduced the pressure to innovate.
5. The central question is sectoral: The real issue is whether tariffs are reducing research investment, or whether the affected industries already had weak R&D capabilities.

Tariff-Exposed Sectors Have Historically Low R&D Spending

1. Tariff exposure and research barely overlap: Organic chemicals, plastics, metals, machinery, auto components and leather face trade shocks but have historically invested little in R&D.
2. Metals have particularly weak research intensity: Indian metals firms spend about 0.4% of sales on R&D, compared with nearly 1.6% globally, showing a longstanding gap.
3. Automobiles perform better but still lag: Indian auto and parts makers spend slightly above 2% of sales on R&D, against the global average of 5%.
4. Electrical equipment also remains below global levels: Electrical equipment firms spend less than 2% on R&D, compared with the same 5% global benchmark.
5. Pharmaceuticals and automobiles dominate research: India’s research effort is concentrated mainly in pharmaceuticals and automobiles, while most other industries contribute very little.
6. Tariffs cannot remove absent R&D: Duties on chemicals or steel cannot substantially reduce research spending in sectors that had very limited research investment beforehand.

Tariffs Have Not Caused the Decline in Research

1. Weak R&D predates recent tariff measures: Exposed industries had followed a low-research path well before 2018, showing that their weakness has deeper causes.
2. Patent trends show no clear tariff effect: Patenting and R&D spending in exposed sectors show no clear break during tariff years that can be attributed to U.S. duties.
3. Tariffs are mainly a trade symptom: The duties reflect a strained trading relationship rather than being the main cause of India’s weak innovation performance.
4. Indian industry has long avoided risky research: Companies have generally preferred short-term profitability and proven technologies because R&D involves long timelines and uncertain outcomes.
5. Industrial culture affects R&D decisions: Indian entrepreneurs have often lacked the risk-taking and long-term research culture seen in countries such as Japan, South Korea and Taiwan.
6. Competition can matter more than protection: Greater competition can push firms towards technological improvement, while continued tariff protection can allow weak innovation habits to persist.

The Real Weakness: India’s Low and Narrow R&D Base

1. Low R&D intensity: The World Intellectual Property Organization (WIPO) comparison cited in the source placed India 55th in R&D expenditure intensity, with R&D spending at only 0.64% of GDP.
2. Total R&D spending has increased: India’s R&D expenditure rose from $20.8 billion in 2000 to $75.7 billion in 2024, but intensity remains weak.
3. China has expanded far faster: China’s R&D spending increased from $40.7 billion to $785.9 billion between 2000 and 2024, widening the gap substantially.
4. Private industry contributes too little: Indian entrepreneurs finance only 36% of R&D, while private-sector contributions exceed 70% in leading economies.
5. Vietnam shows the private-sector gap: Vietnam, another lower-middle-income economy, finances 90.5% of its R&D through private sources, far above India.
6. Industry research often remains routine: Much corporate R&D focuses on routine development and testing, rather than research capable of creating new products.
7. Technology investment remains limited despite large corporate commitments: The Tata, Ambani and Adani groups have committed thousands of crores to semiconductors, petrochemicals, infrastructure and alternative energy, but technology investment remains limited except in a handful of Tata firms.
8. The scale gap is stark: Nvidia alone spends nearly as much on research as all Indian industry combined, showing the weakness of India’s private R&D base.

Way Forward

1. Move towards higher-value products: Tariff-exposed industries should invest in differentiated products that are harder to replace through tariff competition.
2. Link support with R&D effort: Government relief should be tied to actual research spending, so support builds technological capability instead of preserving low-value production.
3. Prioritise core research: R&D incentives should focus on new-product research rather than routine development and testing.
4. Extend support to traditional industries: The ₹1 lakh crore Research, Development and Innovation scheme should also address older exposed sectors such as chemicals and auto components, not only frontier technologies.
5. Offset tariff-linked costs selectively: Higher metal costs for downstream engineering firms can be offset where firms continue investing in research.
6. Protect research-intensive sectors: Pharmaceuticals and automobiles need attention in future trade negotiations because tariffs affecting these sectors can directly affect innovation.
7. Improve R&D measurement: Faster and more complete firm-level data on private R&D spending and exports would help policymakers identify problems and respond early.
8. Strengthen private-sector commitment: Indian companies need greater willingness to fund long-term, risky research so that industrial competitiveness is supported by domestic technological capability.

Conclusion

The evidence suggests that U.S. tariffs are not the principal reason for India’s weak research performance. Most tariff-exposed industries had limited R&D activity long before recent trade tensions. The deeper challenge is India’s low research intensity, weak private-sector participation and narrow innovation base. Strengthening industrial R&D capability remains more important than tariff relief for improving long-term competitiveness.

Question for practice:

Examine whether U.S. tariffs are the main reason for India’s weak research and development performance.

Source: The Hindu